Prodesse, a developer of assays for infectious disease detection, will add to its offerings the first diagnostic assay using light upon extension (LUX) technology developed by Invitrogen, and in turn expose Invitrogen's technologies to its global distribution capabilities....
A new legal challenge to stem cell patents held by the Wisconsin Alumni Research Foundation will trace the history of stem cell development, which critics say predates the work of UW researcher James Thomson. WARF, armed with a $1.5 billion endowment, is promising a vigorous...
In his most recent article, Michael Rosen mentioned that the medical device market (which he thought included the IVD market) probably broke the $200 billion sales revenue mark last year. In fact, according to a market research firm, sales for 2005 topped $220 billion and...
The federal government will continue to draw lines around human embryonic stem cell research following President Bush's veto of the Stem Cell Research Enhancement Act. The House of Representatives fell well short of the two-thirds required to override....
Centricity, the brand name for GE Healthcare's Electronic Health Record, has won the seal of approval from a federal commission that was established to reduce the risk for hospitals and physicians that implement Electronic Health Records....
The United States Senate, defying the threat of a presidential veto, voted overwhelmingly to modify President Bush's ban on new federal funding for embryonic stem cell research. However, the 63 votes in favor of a less restrictive policy is not enough to override a promised...
These are heady days for TomoTherapy, the Madison-based medical device manufacturer that recently opened a new production facility. But the company's top executives say they don't need to come calling on Wall Street, at least not yet....
Taking yet another opportunity to promote stem cell research, Gov. Jim Doyle urged the United States Senate to modify federal policy on funding for human embryonic stem cell lines. A vote could come Tuesday following 12 hours of Senate debate over two days. ...
Imagine, for a moment, that you're a Wisconsin life sciences company and you have a sales rep in biotech hotbeds like San Francisco or Boston. Sound like a dream? Madison's NeoClone is trying to see if it can become a reality with the help of...
Wisconsin Technology Council President Tom Still weighs in on the national stem cell debate, calling for passage of the Stem Cell Research Enhancement Act now being debated in the United States Senate....